Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Authors' Reply: Nephron-Segment Composition and Apparent Fatty Acid Oxidation Suppression in Pkd1KO+Glis3KO Kidneys.
Journal: Journal of the American Society of Nephrology : JASN
Published: August 03, 2026
Cilia to basement membrane signaling is a biomechanical driver in models of autosomal dominant polycystic kidney disease.
Journal: The Journal of clinical investigation
Published: June 30, 2026
PERADIGM: Phenotype embedding similarity-based rare disease gene mapping.
Journal: PLoS genetics
Published: August 13, 2025
A T-cell intrinsic Role for APOL1 Risk Alleles in Allograft Rejection.
Journal: bioRxiv : the preprint server for biology
Published: August 12, 2025
Glis3 Is a Modifier of Cyst Progression in Autosomal Dominant Polycystic Kidney Disease.
Journal: Journal of the American Society of Nephrology : JASN
Published: August 01, 2025
Glis3 is a modifier of cyst progression in autosomal dominant polycystic kidney disease.
Journal: bioRxiv : the preprint server for biology
Published: July 15, 2025
Polycystin-1 acts as an atypical adhesion GPCR that responds to novel Wnt signaling and mechanical stimuli.
Journal: bioRxiv : the preprint server for biology
Published: June 06, 2025
Optimizing next-generation sequencing for genetic diagnosis in autosomal dominant polycystic kidney disease.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: March 23, 2025
APOL1 risk alleles modulate T cell receptor signaling to promote allograft rejection.
Journal: The Journal of clinical investigation
Published: March 07, 2025
Adamts1 and Cyst Expansion in Polycystic Kidney Disease.
Journal: Journal of the American Society of Nephrology : JASN
Published: June 27, 2024
Efficient and selective kidney targeting by chemically modified carbohydrate conjugates.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 16, 2024
A synthetic agent ameliorates polycystic kidney disease by promoting apoptosis of cystic cells through increased oxidative stress.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 19, 2024
Last Updated: 09/26/2026